KELLY SMITH: Open Payments
NPI 1962879155 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,701 in 114 payments from 20 companies in 2025. Trend: 2023 $1,139 · 2024 $1,567 · 2025 $1,701
Food & beverage: $1,701
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $278 |
| AstraZeneca Pharmaceuticals LP | 13 | $274 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $198 |
| PFIZER INC. | 8 | $154 |
| Otsuka America Pharmaceutical, Inc. | 11 | $150 |
| Novo Nordisk Inc | 21 | $140 |
| Axsome Therapeutics, Inc. | 3 | $95 |
| Amgen Inc. | 4 | $74 |
| ABBVIE INC. | 4 | $66 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
Products named: Kerendia, MOUNJARO, REXULTI, AIRSUPRA, NURTEC ODT, Wegovy, Auvelity, JARDIANCE.
Industry payments across IN — which companies pay providers there.
